New drug combo aims to outsmart tough cancers
Disease control
Recruiting now
This early-stage trial tests a new drug called KGX101, given alone or with another immunotherapy (envafolimab), in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check safety and find the best dose. About 57 p…
Phase: PHASE1 • Sponsor: Kangabio AUSTRALIA LTD PTY • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC